Skip to main content

BME Professor Michael Ramsey, who is faculty member in the UNC Departments of Chemistry and Applied Physical Sciences, is the founder of 908 Devices Inc, which received funding from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). Launched in 2017, NIIMBL is a nation-wide consortium aimed at accelerating innovations that make biopharmaceutical manufacturing faster, safer, and lower in cost. Through participation in NIIMBL and engagement with partners, the universities of North Carolina at Chapel Hill and North Carolina State University continue to develop technologies and innovations that meet the needs of North Carolina’s biopharmaceutical industry.

“So that’s what the NIIMBL project was about — advancing the abilities of biomanufacturers to produce the best products possible,” Ramsey says. Indeed, Professor Ramsey’s 908 Devices is the perfect example of a pioneering company at the interface between academics in the laboratory, the implementation of technology developed at UNC, and additional industry funding from major pharmaceutical companies. To read more about Prof Ramsey’s NIIMBL project and the importance of UNC-NCSU partnerships, you can visit the UNC Research website here.

Comments are closed.